Tower Research Capital LLC (TRC) - ARCUTIS BIOTHERAPEUTICS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ARCUTIS BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$20,513
-82.0%
3,863
-67.8%
0.00%
-75.0%
Q2 2023$114,274
+393948.3%
11,991
+357.0%
0.00%
+300.0%
Q1 2023$29
-77.9%
2,624
-70.4%
0.00%
-80.0%
Q4 2022$131
-99.8%
8,865
+213.3%
0.01%
+400.0%
Q3 2022$54,000
-78.7%
2,830
-76.2%
0.00%
-83.3%
Q2 2022$253,000
+1481.2%
11,877
+1282.7%
0.01%
Q1 2022$16,000
-57.9%
859
-52.3%
0.00%
-100.0%
Q4 2021$38,000
+65.2%
1,799
+80.6%
0.00%0.0%
Q3 2021$23,000
-70.5%
996
-65.1%
0.00%
-50.0%
Q2 2021$78,000
+116.7%
2,856
+132.4%
0.00%
+100.0%
Q1 2021$36,000
+227.3%
1,229
+223.4%
0.00%
Q4 2020$11,000
-96.7%
380
-96.6%
0.00%
-100.0%
Q3 2020$332,000
+591.7%
11,340
+615.9%
0.00%
+100.0%
Q2 2020$48,000
+26.3%
1,584
+25.5%
0.00%0.0%
Q1 2020$38,0001,2620.00%
Other shareholders

There were no reported owners of ARCUTIS BIOTHERAPEUTICS INC in Q4 2023.

NameSharesValueWeighting ↓
View complete list of ARCUTIS BIOTHERAPEUTICS INC shareholders